Phosphorylation of androgen receptor serine 81 is associated with its reactivation in castration-resistant prostate cancer-Reference-Cited by-同舟云学术

Phosphorylation of androgen receptor serine 81 is associated with its reactivation in castration-resistant prostate cancer

Published:2018-12 Issue: Volume:438 Page:97-104
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Russo Joshua W.,Liu Xiaming,Ye Huihui,Calagua Carla,Chen Sen,Voznesensky Olga,Condulis James,Ma Fen,Taplin Mary-Ellen,Einstein David J.,Balk Steven P.,Chen Shaoyong

Funder

NIH

DOD

NIH P01

SPORE

DOD Prostate Cancer Research Program Early Investigator Award

Prostate Cancer Foundation Young Investigator Award

DF/HCC A. David Mazzone Awards Program

Natural Science Foundation of Hubei Province in China

National Natural Science Foundation of China

DOD Prostate Cancer Research Program Physician Research Award

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference25 articles.

1. Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer;Watson;Nat. Rev. Canc.,2015

2. Androgen receptor functions in castration-resistant prostate cancer and mechanisms of resistance to new agents targeting the androgen axis;Yuan;Oncogene,2014

3. Androgen signaling in prostate cancer;Dai;Cold Spring Harb Perspect Med,2017

4. Post-translational modification of the androgen receptor;Gioeli;Mol. Cell. Endocrinol.,2012

5. Activation of beta-catenin signaling in prostate cancer by peptidyl-prolyl isomerase Pin1-mediated abrogation of the androgen receptor-beta-catenin interaction;Chen;Mol. Cell Biol.,2006

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CDK9 inhibition inhibits multiple oncogenic transcriptional and epigenetic pathways in prostate cancer;British Journal of Cancer;2024-08-08

2. Androgen receptor post-translational modifications and their implications for pathology;Biochemical Society Transactions;2024-07-03

3. PROTACs targeting androgen receptor signaling: Potential therapeutic agents for castration-resistant prostate cancer;Pharmacological Research;2024-07

4. Androgen receptor splice variants drive castration-resistant prostate cancer metastasis by activating distinct transcriptional programs;Journal of Clinical Investigation;2024-04-30

5. Androgen‐repressed lncRNA LINC01126 drives castration‐resistant prostate cancer by regulating the switch between O‐GlcNAcylation and phosphorylation of androgen receptor;Clinical and Translational Medicine;2024-01